Table 2.
Proportion of etiological subgroups in CNP III, CNP IV, CNP VI, and multiple OMNP
| Etiologies | CNP III ≈% (n = 147) | CNP IV ≈% (n = 71) | CNP VI ≈% (n = 210) | Multiple ≈% (n = 46) |
|---|---|---|---|---|
| Idiopathic | 15.6% (23) | 39.4% (28) | 27.1% (57) | 6.5% (3) |
| Diabetogenic | 13.6% (20) | 21.1% (15) | 13.3% (28) | 0 |
| Space-occupying lesions thereof: | 20.4% (30) | 2.8% (2) | 18.6% (39) | 23.9% (11) |
| –Intraorbital | 0.7% (1) | 0 | 1.0% (2) | 4.3% (2) |
| –Lesions close to the cavernous sinus | 9.5% (14) | 1.4% (1) | 4.8% (10) | 13.0% (6) |
| –Intracerebral, meningeal, intrathecal | 10.2% (15) | 1.4% (1) | 12.9% (27) | 6.5% (3) |
| Inflammation thereof: | 27.2% (40) | 25.4% (18) | 30% (63) | 67.4% (31) |
| –Autoimmune/inflammatory | 22.4% (33) | 19.7% (14) | 23.8% (50) | 54.3% (25) |
| –Viral, bacterial | 4.8% (7) | 5.6% (4) | 6.2% (13) | 13.0% (6) |
| Brainstem infarctions | 19.7% (29) | 9.9% (7) | 7.1% (15) | 2.2% (1) |
| Others | 3.4% (5) | 1.4% (1) | 3.8% (8) | 0 |